Background: Children with attention deficit hyperactivity disorder (ADHD) are vulnerable to the psychological impact of traumatic events due to inherent difficulties in emotion regulation and executive functioning. This study examines the predictive roles of attachment styles and family functioning on depressive, anxiety, and posttraumatic stress disorder (PTSD) symptoms in children with ADHD following the 2023 Türkiye earthquakes. Methods: A longitudinal design was employed with 124 children diagnosed with ADHD, assessed at 3 months (T1) and 12 months (T2) after the earthquakes. Attachment styles were evaluated using the Three-Dimensional Attachment Styles Scale, and family functioning was assessed via the Family Assessment Device. Psychological symptoms were measured using the Children’s Depression Inventory, State-Trait Anxiety Inventory, and Children’s Revised Impact of Event Scale-13. Hierarchical multiple regression analyses were conducted to identify predictors of T2 emotional outcomes. Results: Significant reductions were observed in depressive, state anxiety, and PTSD symptoms between T1 and T2, while trait anxiety remained stable. Poor family functioning and insecure attachment styles, particularly anxious attachment, were robust predictors of elevated emotional symptoms at follow-up. Avoidant attachment was uniquely associated with PTSD symptoms but not with depression or anxiety. Pharmacological treatment was related to lower symptom severity across all domains. Conclusions: The findings underscore the influence of relational and familial factors in shaping psychological responses to disaster-related trauma in children with ADHD. Post-disaster interventions should incorporate attachment-informed and family-centered approaches alongside pharmacological treatment to optimize recovery in this high-risk group.
This paper presents two pediatric cases diagnosed with both Neurofibromatosis Type 1 (NF1) and Attention-Deficit/Hyperactivity Disorder (ADHD), highlighting the neurodevelopmental challenges and management strategies associated with this comorbidity. Two male patients with genetically confirmed NF1 and coexisting ADHD were comprehensively evaluated in terms of clinical presentation, developmental history, diagnostic assessments, and therapeutic interventions. Both cases exhibited marked developmental delays, attentional deficits, and significant academic difficulties. One patient also presented with comorbid epilepsy and motor coordination problems, further complicating the clinical picture. Multimodal treatment approaches partially improved functional and academic outcomes, including stimulant pharmacotherapy and individualized educational support. These cases underscore the importance of early recognition and multidisciplinary management of ADHD in children with NF1 to optimize long-term neurodevelopmental and academic trajectories. Effective long-term care requires genetic counseling, regular clinical follow-up, and close collaboration among neurology, psychiatry, and educational professionals.
This case report highlights the importance of excluding neurological etiologies and employing a multidisciplinary approach in children presenting with tic-like symptoms. It describes the clinical and diagnostic process of a seven-year-old male initially referred to the child psychiatry clinic with a presumptive diagnosis of tic disorder, who was later redirected to pediatric neurology due to concerns about an underlying neurological condition. The patient exhibited intermittent, involuntary muscle twitches in the right eye and right hand. Electroencephalography (EEG) revealed sharp wave activity in the right frontotemporal region, while brain magnetic resonance imaging (MRI) demonstrated a nonspecific T2/FLAIR hyperintensity in the left frontoparietal area. Cerebrospinal fluid (CSF) analysis and infection panels were unremarkable. Clinical improvement was observed following treatment with intravenous immunoglobulin (IVIG) and pulse corticosteroids. This case underscores that tic-like symptoms are not always indicative of primary tic disorders and should prompt thorough evaluation for alternative etiologies, including epileptic activity, structural brain abnormalities such as focal cortical dysplasia, and post-inflammatory neurological processes..
10 October 2026 in Psikiyatride Güncel Yaklaşımlar
Objective: The aim of this study was to describe active psychotropic medication records and agent-level patterns in children and adolescents with autism spectrum disorder (ASD), estimate psychotropic polypharmacy, and identify characteristics associated with an active psychotropic medication record. Method: This single-centre retrospective cross-sectional study included patients with ASD aged 36–216 months who attended a tertiary child and adolescent psychiatry clinic during 2025. Of 172 records assessed, five patients with cognitive impairment attributable to an identified cause other than ASD were excluded; 167 were analysed. Current medications not documented as discontinued were classified as active. Polypharmacy was defined as at least two active psychotropic medications at the same visit. Results: At least one active psychotropic medication was recorded for 123 patients (73.7%; 95% CI 66.5%–79.7%), and polypharmacy for 94 (56.3%; 95% CI 48.7%–63.6%); among the 123 patients with an active record, the polypharmacy proportion was 76.4%. At least one antipsychotic was recorded for 112 patients (67.1%) and at least two for 30 (18.0%). ADHD (aPR = 2.51; 95% CI 1.77–3.55) and irritability (aPR = 1.55; 95% CI 1.28–1.89) were independently associated with an active medication record. Conclusion: Active psychotropic medication records and record-based polypharmacy were frequent in this tertiary-care sample, reflecting electronic health record documentation rather than confirmed medication intake.
28 February 2025 in Journal of Eurasian Medical Science
Purpose: This study aimed to evaluate psychiatric morbidity and consultation patterns among hospitalized pediatric hematology-oncology patients and to identify clinical factors associated with psychiatric diagnoses.Materials and Methods: This retrospective cross-sectional chart review was conducted at the pediatric hematology-oncology inpatient service of Adana City Training and Research Hospital. Medical records of patients aged 0–18 years who were hospitalized in the pediatric hematology-oncology service and received a child and adolescent psychiatry consultation between September 2022 and September 2025 were reviewed. Psychiatric diagnoses were established according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Results: A total of 126 unique pediatric hematology-oncology inpatients were included (mean age: 10.9 ± 4.6 years; 58.7% male). A psychiatric diagnosis was established in 76 patients (60.3%). The most common diagnoses were adjustment disorder in 26 patients (20.6%), major depressive disorder in 21 (16.7%), and anxiety disorders in 16 (12.7%). In multivariable analysis, female sex (OR: 3.23, 95% CI: 1.36–7.68), metastatic disease (OR: 2.63, 95% CI: 1.07–6.49), and low treatment adherence (OR: 6.42, 95% CI: 1.96–21.03) were independently associated with psychiatric diagnosis.Conclusion: Psychiatric morbidity is highly prevalent among hospitalized pediatric hematology-oncology patients requiring psychiatric consultation. Female sex, metastatic disease, and poor adherence to oncological treatment were identified as independent risk factors for psychiatric diagnosis.